Vaccination schedule for adolescents. Consensus of the AEV, CAV-AEP and SEMA

An Pediatr (Engl Ed). 2023 Aug;99(2):122-128. doi: 10.1016/j.anpede.2023.07.004. Epub 2023 Jul 22.

Abstract

We present the consensus document on the immunization schedule for adolescents developed by 3 scientific societies: the Spanish Association of Pediatrics (AEP), through its Advisory Committee on Vaccines (CAV-AEP), the Spanish Society of Adolescent Medicine (SEMA) and the Spanish Association of Vaccinology (AEV). There are particularities in infectious disease during adolescence, such as an increased susceptibility to pertussis, poorer outcomes of chickenpox, mumps and hepatitis A, a high incidence of sexually transmitted infections or increased prevalence of meningococcal carriage. The document analyses the schedule for adolescents in the context of vaccination policy overall. It contemplates the vaccines to be included in the immunization schedule for healthy adolescents: against invasive meningococcal disease (tetravalent ACWY and B), against human papillomavirus (which should be gender-neutral), against pertussis, against influenza and against SARS-CoV-2 (in unvaccinated individuals and at-risk groups). It is worth noting that the 4CMenB vaccine appears to confer some protection against gonococcal infection, which would be a considerable added value for adolescents. The vaccination of adolescents belonging to risk groups or travelling abroad also needs to be contemplated, as is the case in any other age group. Vaccination against hepatitis A, which is included in the routine immunization schedule of Catalonia, Ceuta and Melilla from the second year of life, should also be considered a priority in adolescents traveling to endemic areas.

Keywords: Adolescent; Adolescente; Calendario de inmunización; Grupos de riesgo; Immunization schedule; Risk groups; Vaccines; Vacunas.

MeSH terms

  • Adolescent
  • Adolescent Medicine*
  • COVID-19*
  • Child
  • Consensus
  • Hepatitis A*
  • Humans
  • Immunization Schedule
  • Meningococcal Infections*
  • Meningococcal Vaccines*
  • SARS-CoV-2
  • Vaccination
  • Whooping Cough*

Substances

  • Meningococcal Vaccines